Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.15 - $0.45 $1,887 - $5,661
-12,582 Reduced 38.29%
20,274 $3,000
Q4 2023

Feb 14, 2024

BUY
$0.26 - $0.51 $8,542 - $16,756
32,856 New
32,856 $14,000
Q4 2022

Feb 14, 2023

BUY
$0.77 - $1.62 $12,239 - $25,749
15,895 New
15,895 $12,000

Others Institutions Holding NHWK

About NightHawk Biosciences, Inc.


  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.